Boyun Deng
Zhanjiang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Pan-cancer analysis of TRPV1: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction.
Journal: BMC cancer
Published: November 04, 2025
Solitary fibrous tumor of the chest wall with Doege-Potter syndrome: a case report.
Journal: Frontiers in oncology
Published: May 18, 2025
HOXC-AS1: A Key Biomarker for Prognosis and Immunotherapy in Lung Adenocarcinoma.
Journal: Current computer-aided drug design
Published: October 10, 2024
Pembrolizumab therapy in a patient with NSCLC and bullous pemphigoid: A case report.
Journal: Oncology letters
Published: April 09, 2024
Pan-mediastinal neoplasm diagnosis via nationwide federated learning: a multicentre cohort study.
Journal: The Lancet. Digital health
Published: October 15, 2022
LINC01224/ZNF91 Promote Stem Cell-Like Properties and Drive Radioresistance in Non-Small Cell Lung Cancer.
Journal: Cancer management and research
Published: March 31, 2021
Epigenetic activation of FOXF1 confers cancer stem cell properties to cisplatin‑resistant non‑small cell lung cancer.
Journal: International journal of oncology
Published: June 14, 2019
HGF/MET Regulated Epithelial-Mesenchymal Transitions And Metastasis By FOSL2 In Non-Small Cell Lung Cancer.
Journal: OncoTargets and therapy
Published: May 29, 2019
Epigenetic activation of hepatocyte growth factor is associated with epithelial-mesenchymal transition and clinical outcome in non-small cell lung cancer.
Journal: Journal of Cancer
Published: September 17, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026